SynthesisBMC cancer2025

Incidence and risk of endocrine and metabolic abnormalities linked to PARP inhibitors in solid tumors: a meta-analysis.

Shunlian Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.